Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 364 across all filing types
Latest filing 2021-09-01 Board/Management Inform…
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Advisory Board appointment of Professor Jonathan Clark AM 2 pages 113.6KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 2 September 2021 from Singular Health Group Ltd. It announces the appointment of Professor Jonathan Clark AM to the newly formed advisory Board. The content focuses on the advisory board formation, the background of the appointee, and the terms of his engagement including options issuance. There are no financial statements, no quarterly or annual results, no voting results, no legal proceedings, no capital changes, and no regulatory certifications. The document is a corporate announcement about management/board-related changes, specifically the formation of an advisory board and appointment of a member. This fits best under Board/Management Information (MANG). The document length is 4639 characters, which is consistent with a typical announcement rather than a full report. Therefore, the classification is MANG with high confidence.
2021-09-01 English
Appendix 4E - Preliminary Final Report 30 June 2021 12 pages 199.9KB
Annual Report Classification · 95% confidence The document is titled 'APPENDIX 4E' and is provided to the ASX under Listing Rule 4.3A, which is a regulatory requirement for preliminary final reports. It includes detailed financial statements such as the Consolidated Statement of Profit or Loss, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows for the year ended 30 June 2021. The document also contains notes to the financial statements and explanations of results. It is a comprehensive financial report covering a full fiscal year with substantive financial data and analysis. The document is not merely an announcement or a certification but contains the actual financial report data. Therefore, it fits the definition of an Annual Report (10-K equivalent). FY 2021
2021-08-30 English
Launch of Mobile 3D Scan App For Patient Communication 3 pages 187.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 18 August 2021 from Singular Health Group Ltd. It describes the launch of a new mobile medical image visualization app called 3Dicom Mobile. The content focuses on product features, benefits, and company statements rather than financial results, management changes, or regulatory filings. There is no indication of financial data, earnings, board changes, or voting results. The document is a corporate announcement about a product launch and related technology, which fits best under a general regulatory announcement category rather than a financial or governance report. It is not a report publication announcement since it does not mention the release or availability of a report, nor is it a certification or legal proceeding. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2021-08-17 English
Application for quotation of securities - SHG 6 pages 27.2KB
Capital/Financing Update Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the number and type of securities to be quoted, issue dates, and escrow expiration. It is an announcement related to capital market activities, specifically about securities quotation and capital structure changes. There is no financial performance data, management discussion, or audit information. The content fits the category of Capital/Financing Update, as it concerns changes in the company's capital structure and securities quotation.
2021-08-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 504.6KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 29 July 2021 titled 'ACTIVITIES REPORT FOR THE QUARTER – 30 JUNE 2021'. It provides a detailed quarterly update on the company's activities, including investments, acquisitions, product development, research and development, business expenditure, and corporate activities. It also includes an Appendix 4C Quarterly cash flow report, which is a regulatory requirement for Australian listed entities to report quarterly cash flows. The document contains substantive financial data and analysis for the quarter ended 30 June 2021, including cash flow statements and expenditure breakdowns. This matches the characteristics of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial statements and substantive financial data. The document is not merely an announcement of a report but includes the report content itself. Therefore, the appropriate classification is IR with high confidence. Q4 2021
2021-07-28 English
Application for quotation of securities - SHG 6 pages 27.2KB
Capital/Financing Update Classification · 95% confidence The document is an application for quotation of securities on the ASX (Australian Securities Exchange) for Singular Health Group Ltd. It details the number and type of securities to be quoted, the expiry of escrow periods, and issued capital following quotation. This is a regulatory announcement related to capital market activities, specifically the listing or quotation of securities. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement or certification. The content fits best under the category of Capital/Financing Update (CAP), as it concerns the quotation of securities and capital structure changes.
2021-07-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.